Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  1,142 نتائج ل ""Adolescent""

فلترة النتائج

Publication : european journal of haematology
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Assessment of joint bleeding and target joints in patients with severe or moderately severe hemophilia B (factor IX ≤2%) receiving prophylaxis with rIX-FP in the PROLONG-9FP clinical trial program.

  • Authors : Laws HJ; Department of Paediatric Oncology, Haematology and Clinical Immunology, Centre for Child and Adolescent Health, University of Düsseldorf, Düsseldorf, Germany.; Fukutake K

Subjects: Hemophilia B*/Hemophilia B*/Hemophilia B*/complications ; Hemophilia B*/Hemophilia B*/Hemophilia B*/drug therapy ; Hemophilia A*/Hemophilia A*/Hemophilia A*/drug therapy

  • Source: European journal of haematology [Eur J Haematol] 2023 Aug; Vol. 111 (2), pp. 293-299. Date of Electronic Publication: 2023 May 26.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The association of age and adverse events of PEG-asparaginase in a pediatric tertiary care hospital; a retrospective review.

  • Authors : Abbott L; Division of Hematology/Oncology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.; Claveau M

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use ; Hypersensitivity* ; Pancreatitis*/Pancreatitis*/Pancreatitis*/chemically induced

  • Source: European journal of haematology [Eur J Haematol] 2023 Jan; Vol. 110 (1), pp. 32-39. Date of Electronic Publication: 2022 Oct 17.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Comparison of outcomes between Hodgkin's lymphoma patients treated in and outside clinical trials: A study based on the EORTC-Dutch late effects cohort-linked data.

  • Authors : Juul SJ; Department of Oncology, Rigshospitalet, Copenhagen, Denmark.; Kicinski M

Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/epidemiology ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/etiology ; Hodgkin Disease*/Hodgkin Disease*/Hodgkin Disease*/diagnosis

  • Source: European journal of haematology [Eur J Haematol] 2023 Mar; Vol. 110 (3), pp. 243-252. Date of Electronic Publication: 2022 Nov 25.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Cost-effectiveness of recombinant factor VIII Fc versus emicizumab for prophylaxis in adults and adolescents with haemophilia A without inhibitors in the UK.

  • Authors : Kragh N; Global Health Economics and Outcomes Research, Swedish Orphan Biovitrum AB (Sobi™), Stockholm, Sweden.; Tytula A

Subjects: Factor VIII*/Factor VIII*/Factor VIII*/therapeutic use ; Hemophilia A*/Hemophilia A*/Hemophilia A*/therapy; Humans

  • Source: European journal of haematology [Eur J Haematol] 2023 Mar; Vol. 110 (3), pp. 262-270. Date of Electronic Publication: 2022 Dec 11.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Advanced clinical parameters: A complementary hydroxyurea adherence evaluation in sickle cell anemia treatment.

  • Authors : Moreira ID; Graduate Program in Health Sciences, Federal University of Health Sciences of Porto Alegre, Porto Alegre/RS, Brazil.; Lessa CLM

Subjects: Hydroxyurea*/Hydroxyurea*/Hydroxyurea*/therapeutic use ; Anemia, Sickle Cell*/Anemia, Sickle Cell*/Anemia, Sickle Cell*/diagnosis ; Anemia, Sickle Cell*/Anemia, Sickle Cell*/Anemia, Sickle Cell*/drug therapy

  • Source: European journal of haematology [Eur J Haematol] 2022 Dec; Vol. 109 (6), pp. 736-748. Date of Electronic Publication: 2022 Sep 13.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The safety of Bruton's tyrosine kinase inhibitors in B-cell malignancies: A systematic review.

  • Authors : Arustamyan M; Section of Clinical Cardiology, Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland, Ohio, USA.; Cleveland Clinic, Section of Leukemia/Lymphoma, Department of Hematology and Medical Oncology, Cleveland, Ohio, USA.

Subjects: Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/adverse effects ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy; Humans

  • Source: European journal of haematology [Eur J Haematol] 2022 Dec; Vol. 109 (6), pp. 696-710. Date of Electronic Publication: 2022 Sep 29.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Busulfan and cyclophosphamide-based conditioning regimen still holds the promise of being a safe and efficacious regimen for allogeneic transplantation in patients with transfusion-dependent thalassemia, even in high risk.

  • Authors : Mehta P; Department of Hematology and Bone Marrow Transplant Unit, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.; Kapoor J

Subjects: Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/diagnosis ; Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/etiology ; Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/prevention & control

  • Source: European journal of haematology [Eur J Haematol] 2022 Nov; Vol. 109 (5), pp. 447-457. Date of Electronic Publication: 2022 Jul 26.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Real-world data on voxelotor to treat patients with sickle cell disease.

  • Authors : Muschick K; Prisma Health-Upstate Comprehensive SCD Program, Greenville, South Carolina, USA.; Fuqua T

Subjects: Anemia, Sickle Cell*/Anemia, Sickle Cell*/Anemia, Sickle Cell*/diagnosis ; Anemia, Sickle Cell*/Anemia, Sickle Cell*/Anemia, Sickle Cell*/drug therapy; Adolescent

  • Source: European journal of haematology [Eur J Haematol] 2022 Aug; Vol. 109 (2), pp. 154-161. Date of Electronic Publication: 2022 May 26.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Lower levels of cyclosporine between days 0 and +21 may reduce later relapses without increasing graft-versus-host disease in children and adolescents with acute lymphoblastic leukemia who undergo myeloablative TBI-based allogeneic hematopoietic cell transplantation.

  • Authors : Arcuri LJ; Department of Bone Marrow Transplantation, Instituto Nacional de Cancer, Rio de Janeiro, Brazil.; Lerner D

Subjects: Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/diagnosis ; Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/etiology ; Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/prevention & control

  • Source: European journal of haematology [Eur J Haematol] 2022 Aug; Vol. 109 (2), pp. 182-185. Date of Electronic Publication: 2022 May 29.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Effectiveness of long-term prophylaxis using pdFVIII/VWF concentrate in patients with inherited von Willebrand disease.

  • Authors : Rugeri L; Unité Hémostase Clinique, Hospices Civils de Lyon, Bron, France.; Harroche A

Subjects: Factor VIII*/Factor VIII*/Factor VIII*/administration & dosage ; Hemorrhage*/Hemorrhage*/Hemorrhage*/prevention & control ; von Willebrand Diseases*/von Willebrand Diseases*/von Willebrand Diseases*/diagnosis

  • Source: European journal of haematology [Eur J Haematol] 2022 Jul; Vol. 109 (1), pp. 109-117. Date of Electronic Publication: 2022 Apr 29.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  1,142 نتائج ل ""Adolescent""